Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shun Fujimaki
Sorafenib-Inhibited Signaling: Emerging Evidence of RAFIndependent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma
Related publications
Signaling Pathways in Schizophrenia: Emerging Targets and Therapeutic Strategies
Trends in Pharmacological Sciences
Toxicology
Pharmacology
Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma
International Journal of Hematology-Oncology and Stem Cell Research
Oncology
Transplantation
Hematology
Potential Signaling Pathways as Therapeutic Targets for Overcoming Chemoresistance in Mucinous Ovarian Cancer (Review)
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Quantitative Phosphoproteomic Analysis Identifies the Potential Therapeutic Target EphA2 for Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Cells
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Therapeutic Targets in the ASK1-dependent Stress Signaling Pathways
Proceedings of the Japan Academy Series B: Physical and Biological Sciences
Multidisciplinary
Biological Sciences
Medicine
Agricultural
Astronomy
Physics
Signaling Pathways Involved in Molecular Carcinogenesis of Hepatocellular Carcinoma
Emerging Role of Hpo Signaling and YAP in Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
GPCRs as Potential Therapeutic Targets in Preeclampsia
Drug Discovery Today: Disease Models
Drug Discovery
Molecular Medicine
